drugset / Trial / NCT01008904

Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer

NCT01008904

Phase 2 Completed 31 enrolled Virginia Commonwealth University
NaSingle-groupOpen-labelSupportive care

Summary

RATIONALE: Magnesium oxide may help relieve hot flashes in women with cancer. PURPOSE: This phase II trial is studying how well magnesium oxide works in treating hot flashes in menopausal women with cancer.

Timeline

Start
2009-07
Primary completion
2013-01
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Oxide Small molecule 400 mg Oral
Subject Magnesium Oxide Small molecule 800 mg Oral

Indications